Dong-E-E-Jiao Co Ltd
Dong-E-E-Jiao maintains a strong liquidity position, with a current ratio of 3.69 and a low debt-to-equity ratio of 0.01, indicating minimal leverage and strong balance sheet health. The company's market price of 52.26 CNY yields a price-to-earnings ratio of 19.36 and a price-to-book ratio of 3.26, suggesting a moderate valuation relative to its book value and earnings. Free cash flow of 163,067,300 CNY and operating cash flow of 2,289,207,780 CNY further support its ability to fund operations and reinvest in the business. Profitability metrics show a return on equity of 16.82% and a return on assets of 12.99%, both of which are strong indicators of efficient capital use and asset management. The company's gross profit of 4,921,267,020 CNY and operating income of 2,070,532,280 CNY reflect a healthy margin structure, although the net income of 1,738,741,090 CNY is slightly lower, indicating some operating expenses or tax pressures. Geographically, the company is heavily concentrated in the Chinese market, with no disclosed international revenue segments. This concentration may expose the company to domestic regulatory and economic risks, although it also allows for deep market penetration and brand recognition. The company's revenue of 6,700,474,180 CNY and net income of 1,738,741,090 CNY suggest a stable growth trajectory, supported by strong cash flow generation and a solid balance sheet. Analysts have set a mean price target of 74.69 CNY, with a median of 75.00 CNY, indicating a positive outlook for the stock. Risk factors include a medium liquidity risk due to negative net cash after subtracting total debt, and a low dilution risk, with no significant dilution potential in the near term. The company's capital structure is conservative, with long-term debt of only 62,260,140 CNY, and a capital expenditure of -82,671,900 CNY, indicating a focus on cash preservation rather than aggressive expansion. Recent events include strong analyst sentiment, with a mean recommendation of 1.78 (1=strong buy, 5=strong sell), and a total of 9 buy recommendations out of 9 total analyst ratings. This indicates a generally positive outlook from the investment community.
Business. Dong-E-E-Jiao Co Ltd is a Chinese pharmaceutical company that produces and sells traditional Chinese medicine (TCM) products, including the well-known Dong'e Ejiao, a gelatin-based product derived from donkey hide.
Classification. The company is classified under the Healthcare economic sector, specifically in the Pharmaceuticals & Medical Research business sector, with a high confidence level of 0.92.
- Dong-E-E-Jiao has a strong liquidity position with a current ratio of 3.69 and low leverage.
- The company's profitability is robust, with a return on equity of 16.82% and a return on assets of 12.99%.
- The stock is moderately valued, with a price-to-earnings ratio of 19.36 and a price-to-book ratio of 3.26.
- Analysts have a positive outlook, with a mean price target of 74.69 CNY and a median of 75.00 CNY.
- The company is heavily concentrated in the Chinese market, which may pose regulatory and economic risks.
- --
- ## RATIONALES
- ```json
- Net cash is negative after subtracting total debt.